Evidence map›Paper›PMID 35625240›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Genomic Analysis of Multidrug-Resistant Hypervirulent (Hypermucoviscous)

Hisham N Altayb, Hana S Elbadawi, Othman Baothman, Imran Kazmi, Faisal A Alzahrani, Muhammad Shahid Nadeem, Salman Hosawi, Kamel Chaieb

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. A systematic review of hypervirulentFrontiers in medicine · 2025
    Pooled it
  2. Article
  3. Article
  4. Hypermucoviscosity inJournal of bacteriology · 2026
    Review
  5. Article
  6. Genomic Analysis of HypervirulentIranian journal of biotechnology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Multidrug-resistant hypervirulentFuture microbiology · 2025
    Review
  17. Article
  18. mSphere · 2024
    Article
  19. Article
  20. HypervirulentPathogens & immunity · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Hisham N AltaybDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-2635-9383
Hana S ElbadawiMicrobiology and Parasitology Department, Soba University Hospital, University of Khartoum, Khartoum 11115, Sudan.ORCID 0000-0003-2192-7932
Othman BaothmanDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Imran KazmiDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-1881-5219
Faisal A AlzahraniDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-0441-4000
Muhammad Shahid NadeemDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-4112-0925
Salman HosawiDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-0639-1618
Kamel ChaiebDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
King Abdulaziz University · SAUniversity of Khartoum · SDUniversity of Monastir · TN

Funding

King Abdulaziz University IFPRC-072-130-2020
6 · The paper itself

Abstract

Hypervirulent

Indexed as

aerobactinantimicrobial resistancefimbrial proteinshvKPK2 capsuleST14

Identifiers

PMID35625240
PMCPMC9137517
OpenAlexW4225147870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.